Evaluation of SARS-CoV-2 antibody persistence and viral spread in stool: a long-term care experience before COVID-19 vaccination.

Oya Özlem Eren Kutsoylu Ozgur Appak Nazlı Arzu Gokcen Omeroglu-Simsek Nil Tekin Başak Bayram Ayca Arzu SayinerNesim TanglayVildan Avkan Oguz

Published in: Irish journal of medical science (2022)

A durable SARS-CoV-2 IgG antibody response was monitored at least 9 months after the participants were diagnosed with COVID-19. SARS-CoV-2 antibody positivity was detected 76.9% in PCR (+) and 10.0% in PCR (-) participants. Knowing the duration of detectable antibodies is an important finding for developing disease prevention and public health strategies.

Keyphrases

sars cov
public health
long term care
respiratory syndrome coronavirus
coronavirus disease